Study objectives -Since 1986, the national sentinel network in Switzerland (Sentinella) has collected reports of measles, mumps, and rubella cases in order to evaluate the impact of the Swiss MMR vaccination campaign (started in 1987) The national sentinel network in Switzerland (Sentinella) has collected reports of measles, mumps, and rubella cases since 1986. This surveillance is an important part of the evaluation of the MMR immunisation campaign in Switzerland, which started in 19871 with the stated purpose of eliminating measles, mumps, and rubella by improving vaccination coverage in all cantons. A systematic single dose vaccination with a combined MMR vaccine was recommended at the age of 15 to 24 months. All vaccines were free of charge. In general, three different trivalent vaccines were available. In addition, since 1987 unvaccinated children whose parents agree have been systematically vaccinated at school entry (6 to 7 years) and at the age of 15 and 16 at the end of compulsory school. These measures should have lead to a homogeneously high vaccination coverage of the population aged 15 months and 20 years by 1995.
H C Matter, J Cloetta, H Zimmermann and the Sentinella Arbeitsgemeinschaft Abstract Study objectives -Since 1986, the national sentinel network in Switzerland (Sentinella) has collected reports of measles, mumps, and rubella cases in order to evaluate the impact of the Swiss MMR vaccination campaign (started in 1987) on disease frequency. Design -Passive surveillance of clinical measles, mumps, and rubella cases through a voluntary physician based sentinel network in Switzerland. Setting -Each year between June 1986 and May 1994, 150 to 200 general practitioners, specialists in internal medicine, and paediatricians in private practice covering the whole country have reported weekly numbers of consultations. Patients -Every patient who fulfilled the case definition and consulted a physician participating in the Sentinella network was reported.
Main results -Since 1986, the annual number of reported measles cases per physician has fallen -from 1-3 (95% confidence interval (CI) 1 11, 1.50) in 1986-87 to 0-4 (95% CI 0-30, 0.50) in 1993-94. A decreasing trend, although less pronounced, was also observed for rubella. An initial decrease in mumps cases was reported -from 1-8 (95% CI 1-575 2-03) annually reported cases per physician in 1986-87 to 0-7 (95% CI 0-555 0-83) in 1989-90. This was followed, however, by a net and sustained increase. In 1993-94, the mean annual number of reported mumps cases per practitioner reached 4 7 (95% CI 4*34, 5 (fig 2) .
Altogether 19-4% of reported rubella cases were examined serologically between 1986 and 1993, and 47-5% of these gave a positive result. The natural periodicity of the disease may have contributed to the increasing number of cases. The geographic differences may be due to the vaccination coverage in the Romandie, which was about 10% lower than that in the German-speaking part of Switzerland. In 1991, a cross sectional study representative of the whole country was carried out by the Institute of Social and Preventive Medicine in Zurich to assess vaccination coverage in 2 to 3 year old children.'3 Altogether 83% of children included in the study had been vaccinated against measles (one dose) and 80% had documented vaccination against rubella and mumps. Vaccination coverages for measles, rubella, and mumps were 5%, 7%, and 9%, respectively lower in the Romandie than in the Germanspeaking regions. Other studies in geographically limited areas provided similar data for German speaking cantons and showed significantly lower levels of vaccination coverage in the Romandie.'415 In addition, the proportions of children in the Romandie vaccinated with the different vaccines available in Switzerland differed from the rest of the country.
Vaccinated children with mumps might seek medical care more often than unvaccinated children. Therefore, the proportion of vaccinated cases may be biased. This does not, however, explain the steadily increasing proportion of mumps cases reported in vaccinated children since 1986. Three different trivalent vaccines were used in Switzerland. A vaccine containing the Jeryl Lynn strain has been available since 1971, an Urabe AM/9 vaccine since 1983, and a Rubini vaccine since 1986 On the basis of the sentinel data, the overall efficacy of measles and rubella vaccines used in Switzerland was estimated to be above 90%.
The excessive increase in the proportion of vaccinated mumps cases, on the other hand, indicates that the level of protection in the population is still insufficient. Under these conditions, the goal of mumps elimination is unlikely to be reached.
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